{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:17:21Z","timestamp":1790803041500,"version":"4.1.0"},"reference-count":41,"publisher":"Impact Journals, LLC","issue":"34","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,11,3]]},"DOI":"10.18632\/oncotarget.5937","type":"journal-article","created":{"date-parts":[[2015,10,5]],"date-time":"2015-10-05T03:46:00Z","timestamp":1444016760000},"page":"36053-36062","source":"Crossref","is-referenced-by-count":56,"title":["Molecular targeting of protein arginine deiminases to suppress colitis and prevent colon cancer"],"prefix":"10.18632","volume":"6","author":[{"given":"Erin E.","family":"Witalison","sequence":"first","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina, Columbia, SC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangli","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina, Columbia, SC, USA"},{"name":"Shanxi Medical University, Taiyun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey P.","family":"Causey","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of North Florida, Jacksonville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorne J.","family":"Hofseth","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina, Columbia, SC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,9,30]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"G7","DOI":"10.1152\/ajpgi.00079.2004","article-title":"Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation","volume":"287","author":"Yio","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta-analysis","volume":"48","author":"Mayberry","year":"2001","journal-title":"Gut"},{"key":"3","first-page":"616","article-title":"Protein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potential","volume":"12","author":"Thompson","year":"2009","journal-title":"Curr Opin Drug Discov Devel"},{"key":"4","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/bies.10357","article-title":"PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease","volume":"25","author":"Pruijn","year":"2003","journal-title":"Bioessays"},{"key":"5","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.biocel.2006.03.008","article-title":"Citrullination: a posttranslational modification in health and disease","volume":"38","author":"Buz\u00e1s","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"key":"6","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1021\/bi061180d","article-title":"Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization","volume":"45","author":"Thompson","year":"2006","journal-title":"Biochemistry"},{"key":"7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/bip.22127","article-title":"The protein arginine deiminases: Structure, function, inhibition, and disease","volume":"99","author":"Thompson","year":"2013","journal-title":"Biopolymers"},{"key":"8","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.4049\/jimmunol.1201517","article-title":"A citrullinated fibrinogen-specific T cell line enhances autoimmune arthritis in a mouse model of rheumatoid arthritis","volume":"190","author":"Holers","year":"2013","journal-title":"J Immunol"},{"key":"9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jaut.2012.03.004","article-title":"Neuronal PAD4 expression and protein citrullination: possible role in production of autoantibodies associated with neurodegenerative disease","volume":"38","author":"Nagele","year":"2012","journal-title":"J Autoimmun"},{"key":"10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11064-006-9144-5","article-title":"The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis","volume":"32","author":"Wood","year":"2007","journal-title":"Neurochem Res"},{"key":"11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.clim.2007.09.001","article-title":"Haplotypes of PADI4 susceptible to rheumatoid arthritis are also associated with ulcerative colitis in the Japanese population","volume":"126","author":"Tsukamoto","year":"2008","journal-title":"Clin Immunol"},{"key":"12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2407-9-40","article-title":"Increased PADI4 expression in blood and tissues of patients with malignant tumors","volume":"9","author":"Shen","year":"2009","journal-title":"BMC Cancer"},{"key":"13","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/ard.2005.049403","article-title":"Citrullination is an inflammation-dependent process","volume":"65","author":"Catrina","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"14","doi-asserted-by":"crossref","first-page":"G929","DOI":"10.1152\/ajpgi.00435.2010","article-title":"Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor","volume":"300","author":"Hofseth","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"15","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1021\/ml300288d","article-title":"D-amino acid based protein arginine deiminase inhibitors: Synthesis, pharmacokinetics, and in cellulo efficacy","volume":"3","author":"Thompson","year":"2012","journal-title":"ACS Med Chem Lett"},{"key":"16","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.4049\/jimmunol.1001620","article-title":"N-\u03b1-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis","volume":"186","author":"Arend","year":"2011","journal-title":"J Immunol"},{"key":"17","doi-asserted-by":"crossref","first-page":"e53791","DOI":"10.1371\/journal.pone.0053791","article-title":"The induction of microRNA-16 in colon cancer cells by protein arginine deiminase inhibition causes a p53-dependent cell cycle arrest","volume":"8","author":"Hofseth","year":"2013","journal-title":"PLoS One"},{"key":"18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1006\/bbrc.1998.8148","article-title":"Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages","volume":"243","author":"Senshu","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.14348\/molcells.2014.2359","article-title":"Vimentin is involved in peptidylarginine deiminase 2-induced apoptosis of activated Jurkat cells","volume":"37","author":"Hung","year":"2014","journal-title":"Mol Cells"},{"key":"20","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1006\/bbrc.2001.6303","article-title":"Deimination of arginine residues in nucleophosmin\/B23 and histones in HL-60 granulocytes","volume":"290","author":"Yamada","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ncomms1676","article-title":"Regulation of histone modification and chromatin structure by the p53-PADI4 pathway","volume":"3","author":"Matsuda","year":"2012","journal-title":"Nat Commun"},{"key":"22","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.3892\/or.2012.1995","article-title":"miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma","volume":"28","author":"Yang","year":"2012","journal-title":"Oncol Rep"},{"key":"23","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nm.1880","article-title":"The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities","volume":"14","author":"Peschle","year":"2008","journal-title":"Nat Med"},{"key":"24","doi-asserted-by":"crossref","first-page":"725","DOI":"10.5483\/BMBRep.2009.42.11.725","article-title":"Down-regulation of the cyclin E1 oncogene expression by microRNA-16-1 induces cell cycle arrest in human cancer cells","volume":"42","author":"Zhang","year":"2009","journal-title":"BMB Rep"},{"key":"25","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/1541-7786.MCR-10-0344","article-title":"MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E","volume":"9","author":"Ginsberg","year":"2011","journal-title":"Mol Cancer Res"},{"key":"26","first-page":"865","article-title":"Arachidonic acid metabolism and intracellular calcium concentration in inflammatory bowel disease","volume":"7","author":"Vetter","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"27","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.3748\/wjg.v20.i12.3231","article-title":"Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies","volume":"20","author":"Andersen","year":"2014","journal-title":"World J Gastroenterol"},{"key":"28","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1128\/MCB.01747-07","article-title":"Regulation of p53 target gene expression by peptidylarginine deiminase 4","volume":"28","author":"Wang","year":"2008","journal-title":"Mol Cell Biol"},{"key":"29","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1021\/bi200309e","article-title":"Autodeimination of protein arginine deiminase 4 alters protein-protein interactions but not activity","volume":"50","author":"Thompson","year":"2011","journal-title":"Biochemistry"},{"key":"30","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1038\/onc.2010.51","article-title":"Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression","volume":"29","author":"Wang","year":"2010","journal-title":"Oncogene"},{"key":"31","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1073\/pnas.0407159102","article-title":"Regulation of coactivator complex assembly and function by protein arginine methylation and demethylimination","volume":"102","author":"Stallcup","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"32","doi-asserted-by":"crossref","first-page":"17069","DOI":"10.1074\/jbc.M111.230961","article-title":"Citrullination of inhibitor of growth 4 (ING4) by peptidylarginine deminase 4 (PAD4) disrupts the interaction between ING4 and p53","volume":"286","author":"Fast","year":"2011","journal-title":"J Biol Chem"},{"key":"33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1126\/science.1101400","article-title":"Human PAD4 regulates histone arginine methylation levelsdemethylimination","volume":"306","author":"Stallcup","year":"2004","journal-title":"Science"},{"key":"34","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nrg2634","article-title":"Causes and consequences of microRNA dysregulation in cancer","volume":"10","author":"Croce","year":"2009","journal-title":"Nat Rev Genet"},{"key":"35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.molmed.2011.01.008","article-title":"Cancer microRNAs: from subtype profiling to predictors of response to therapy","volume":"17","author":"Weidhaas","year":"2011","journal-title":"Trends Mol Med"},{"key":"36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1158\/1541-7786.MCR-11-0337","article-title":"The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2","volume":"10","author":"Dixon","year":"2012","journal-title":"Mol Cancer Res"},{"key":"37","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature08199","article-title":"Modulation of microRNA processing by p53","volume":"460","author":"Miyazono","year":"2009","journal-title":"Nature"},{"key":"38","doi-asserted-by":"crossref","first-page":"e10615","DOI":"10.1371\/journal.pone.0010615","article-title":"The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex","volume":"5","author":"Boominathan","year":"2010","journal-title":"PLoS One"},{"key":"39","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s12032-011-9880-5","article-title":"Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer","volume":"29","author":"Zhou","year":"2012","journal-title":"Med Oncol"},{"key":"40","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1016\/j.tetlet.2008.05.021","article-title":"An improved synthesis of haloaceteamidine-based inactivators of protein arginine deiminase 4 (PAD4)","volume":"49","author":"Thompson","year":"2008","journal-title":"Tetrahedron Lett"},{"key":"41","first-page":"17","article-title":"Dose translation from animal to human studies revisited","volume":"17","author":"Ahmad","year":"2007","journal-title":"Faseb J"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5937","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T17:47:06Z","timestamp":1589392026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,30]]},"references-count":41,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2015,11,3]]}},"alternative-id":["5937","26440311"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.5937","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,30]]}}}